-
effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Annual Incidence of Foot Ulcer Among Diabetic Medicare Parts A and B Fee-for-Service (FFS)
Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of
Peripheral Artery Disease (PAD)
Algorithm 3: 12-month period of continuous enrollment and continuous FFS enrollment throughout the year.
Age…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
November 01, 2012 - Summary of evidence on comparative benefits and harms
of screening for hepatitis C virus infection (continued … Summary of evidence on comparative benefits and harms
of screening for hepatitis C virus infection (continued … (continued)
Diagnostic accuracy: FIB-4 vs. liver
biopsy
Moderate For severe fibrosis (defined as METAVIR … Summary of evidence on comparative benefits and harms
of screening for hepatitis C virus infection (continued … (continued)
Vertical transmission: Prolonged
rupture of membranes vs. less
prolonged rupture of membranes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
March 01, 2013 - Future Research Recommendations (continued)
Research Gaps Future Research Recommendations
General Issues … (continued)
• Modeling studies to estimate the benefits and harms of
different kidney stone evaluation … Future Research Recommendations (continued)
Research Gaps Future Research Recommendations
Key Question … Future Research Recommendations (continued)
Research Gaps Future Research Recommendations
Key Question … Future Research Recommendations (continued)
Research Gaps Future Research Recommendations
Key Question
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - Characteristics of person-time (after baseline), by medication use (continued)
Characteristic … Characteristics of person-time (after baseline), by medication use (continued)
Characteristic … Characteristics of person-time (after baseline), by medication use (continued)
Characteristic … Rate ratios of MI/SCD—standard adjustment (all variables, including those in the CRS)
(continued) … Rate ratios of MI/SCD—standard adjustment (all variables, including those in the CRS)
(continued)
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - Incidence of diabetic foot ulcer and lower extremity
amputation among Medicare beneficiaries,
2006 to 2008
Diabetic Foot Ulcers Data Points #2
In Medicare Parts A and B fee-for-
service beneficiaries with diabetes, the
incidence of diabetic foot ulcer is about
6.0% and lower extremity amputation
about 0.5%.
Am…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
March 01, 2024 - Continued on page 2
2
Background and Purpose
ADHD is the single most prevalent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - Summary of inclusion and exclusion criteria (continued)
Study
Characteristic Inclusion Criteria Exclusion … Strength of evidence domains for the effect of OC use on ovarian cancer (continued)
Comparison
Number … Strength of evidence domains for the effect of OC use on ovarian cancer (continued)
Comparison
Number … Strength of evidence domains for the effect of OC use on breast cancer (continued)
Comparison
Number … Strength of evidence domains for the effect of OC use on stroke (continued)
Comparison
Number of
Studies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
July 01, 2010 - interventions for RC tears
Strength
Comparison (number of studies) of evidence Summary
Operative techniques (continued … Strength
Comparison (number of studies) of evidence Summary
Nonoperative vs. operative treatment (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-protocol-appendix%20A.pdf
December 09, 2021 - Appendix A: Literature Search
Page 1 of 4
Appendix A: Literature Search
Medline (via PubMed)
(((((postpartum OR post-partum OR postnatal OR post-natal OR puerperal OR puerperium OR
postdelivery OR post-delivery OR "post delivery" OR "Peripartum Period"[Mesh] OR "fourth trimester"
OR "4th trimester") AND ("P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2023-update-executive-summ.pdf
January 01, 2023 - Continued on page 2
2
Background and Purpose
PTSD is a disorder that results
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
October 01, 2020 - (continued on page 2)
2
Background and Purpose
Colonic diverticulitis is caused by
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
December 26, 2022 - the studies,
the themes of the challenges in implementation, as well as if the interventions were continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - initiation and
start of drug holiday, duration
of drug holiday, post-drug
holiday agent/class
Continued … Continued
osteoporosis drug
treatment after >1
yr prior
osteoporosis drug
treatment
See Table … illustrates how long-term osteoporosis drug treatment versus
control and osteoporosis drug holiday versus continued … Comparisons • For treatment efficacy and harms: Placebo, active contemporaneous control
• For drug holiday: Continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Utilization and cost of anticancer biologic products
among Medicare beneficiaries, 2006-2009
Data Points #6Anticancer Biologics
From 2006 to 2009, over 800,000
Medicare fee-for-service
beneficiaries continuously
enrolled in Parts A and B had a
claim for an anticancer biologic
of interest.
Bevacizumab was the m…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - Summary of strength of evidence for major outcomes—KQ 1 (PCOS)
(continued)
10
Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS)
(continued)
11
Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS)
(continued)
12
Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS)
(continued)
Key Question 2. … Summary of strength of evidence for major outcomes—KQ 3 (unexplained
infertility)(continued)
16
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - Continued on page 2
2
Background and Purpose
CRT with 5FU plus MMC
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
January 01, 2011 - Economic burden of diabetic foot ulcers and amputations
Data Points #3Diabetic Foot Ulcers
Beneficiaries with a diabetic foot
ulcer are seen by their outpatient
health care provider about 14 times
per year and are hospitalized about
1.5 times per year. The cost of care
for these beneficiaries is substantial,
at…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
January 01, 2024 - (Continued on page 2)
2
Background and Purpose
Severe maternal morbidity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
October 01, 2010 - of key points and recommendations for quantitative synthesis in Comparative
Effectiveness Reviews (continued … of key points and recommendations for quantitative synthesis in Comparative
Effectiveness Reviews (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
October 01, 2010 - of key points and recommendations for quantitative synthesis in Comparative
Effectiveness Reviews (continued … of key points and recommendations for quantitative synthesis in Comparative
Effectiveness Reviews (continued